New Trend in Weight-Loss Drugs: 'Casual' Users

She didn't want to overhaul her body—just lose a few pounds. In New York magazine, Melissa Dahl profiles an emerging group of "casual" users of GLP-1 drugs like Ozempic, Wegovy, and newer compounds such as retatrutide. They are not obese, not diabetic, and often not working with a doctor...